Sarah Marktel

6.2k total citations
75 papers, 2.3k citations indexed

About

Sarah Marktel is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Sarah Marktel has authored 75 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 33 papers in Genetics and 16 papers in Oncology. Recurrent topics in Sarah Marktel's work include Hematopoietic Stem Cell Transplantation (30 papers), Hemoglobinopathies and Related Disorders (17 papers) and Virus-based gene therapy research (12 papers). Sarah Marktel is often cited by papers focused on Hematopoietic Stem Cell Transplantation (30 papers), Hemoglobinopathies and Related Disorders (17 papers) and Virus-based gene therapy research (12 papers). Sarah Marktel collaborates with scholars based in Italy, United Kingdom and United States. Sarah Marktel's co-authors include Fabio Ciceri, Chiara Bonini, Claudio Bordignon, Catia Traversari, Zulma Magnani, Maria Grazia Roncarolo, Jane F. Apperley, Eduardo Olavarría, Jacopo Peccatori and John M. Goldman and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Blood.

In The Last Decade

Sarah Marktel

74 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Marktel Italy 28 1.1k 782 713 572 563 75 2.3k
Julián Sevilla Spain 26 1.2k 1.1× 485 0.6× 295 0.4× 528 0.9× 344 0.6× 130 2.3k
Paolo de Fabritiis Italy 32 1.8k 1.7× 708 0.9× 814 1.1× 840 1.5× 158 0.3× 199 3.2k
W. Lange Germany 24 599 0.6× 812 1.0× 383 0.5× 514 0.9× 179 0.3× 59 1.9k
Josu de la Fuente United Kingdom 25 895 0.8× 247 0.3× 825 1.2× 619 1.1× 253 0.4× 86 2.1k
Carmem Bonfim Brazil 24 925 0.9× 454 0.6× 248 0.3× 472 0.8× 218 0.4× 146 1.9k
Pietro Merli Italy 26 909 0.8× 442 0.6× 215 0.3× 319 0.6× 150 0.3× 109 1.8k
B.R. Reeves United Kingdom 30 829 0.8× 427 0.5× 417 0.6× 736 1.3× 467 0.8× 54 2.2k
Rinat Bernstein‐Molho Israel 25 577 0.5× 218 0.3× 310 0.4× 594 1.0× 626 1.1× 116 1.9k
N. M. Wulffraat Netherlands 17 586 0.5× 418 0.5× 139 0.2× 755 1.3× 827 1.5× 28 2.3k
Petr Sedláček Czechia 24 867 0.8× 268 0.3× 250 0.4× 301 0.5× 247 0.4× 110 1.6k

Countries citing papers authored by Sarah Marktel

Since Specialization
Citations

This map shows the geographic impact of Sarah Marktel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Marktel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Marktel more than expected).

Fields of papers citing papers by Sarah Marktel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Marktel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Marktel. The network helps show where Sarah Marktel may publish in the future.

Co-authorship network of co-authors of Sarah Marktel

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Marktel. A scholar is included among the top collaborators of Sarah Marktel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Marktel. Sarah Marktel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruno, Alessandro, Raffaella Greco, Daniela Clerici, et al.. (2024). Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience. Frontiers in Oncology. 14. 1391743–1391743. 2 indexed citations
2.
3.
4.
Lorentino, Francesca, Alessandro Bruno, Sarah Marktel, et al.. (2022). Minnesota acute graft-<i>versus</i>-host disease risk score predicts survival at onset of graft-<i>versus</i>-host disease after post-transplant cyclophosphamide prophylaxis. Haematologica. 107(11). 2748–2751. 1 indexed citations
5.
Aprile, Annamaria, Alessandro Gulino, Mariangela Storto, et al.. (2020). Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche. Blood. 136(5). 610–622. 23 indexed citations
6.
Stanghellini, Maria Teresa Lupo, Carlo Messina, Sarah Marktel, et al.. (2020). Following-up allogeneic transplantation recipients during the COVID-19 pandemic. The Lancet Haematology. 7(8). e564–e565. 11 indexed citations
7.
Greco, Raffaella, Giacomo Oliveira, Maria Teresa Lupo Stanghellini, et al.. (2015). Improving the safety of cell therapy with the TK-suicide gene. Frontiers in Pharmacology. 6. 95–95. 95 indexed citations
8.
Martino, Massimo, Mauro Montanari, Felicetto Ferrara, et al.. (2014). Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study. Biology of Blood and Marrow Transplantation. 20(7). 1026–1032. 24 indexed citations
9.
Sala, Elisa, Roberto Crocchiolo, Sara Gandolfi, et al.. (2014). Bendamustine Combined with Donor Lymphocytes Infusion in Hodgkin's Lymphoma Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 20(9). 1444–1447. 18 indexed citations
10.
Noviello, Maddalena, Francesco Saverio Tedesco, Attilio Bondanza, et al.. (2014). Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD. Molecular Therapy. 22(7). 1342–1352. 17 indexed citations
11.
Caocci, Giovanni, Fabio Efficace, Francesca Ciotti, et al.. (2012). Health related quality of life in Middle Eastern children with beta-thalassemia. PubMed. 12(1). 6–6. 87 indexed citations
12.
Bonfiglio, S, Maria Pia Sormani, Andrea Tettamanti, et al.. (2012). Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures. BMC Neurology. 12(1). 91–91. 48 indexed citations
13.
14.
Selleri, Silvia, Immacolata Brigida, Miriam Casiraghi, et al.. (2011). In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency. Journal of Allergy and Clinical Immunology. 127(6). 1368–1375.e8. 8 indexed citations
15.
Cappelli, Barbara, Alessandra Biffi, Robert Chiesa, et al.. (2010). High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 36(1). 14–14. 39 indexed citations
16.
Caocci, Giovanni, Fabio Efficace, Francesca Ciotti, et al.. (2010). Prospective Assessment of Health-Related Quality of Life in Pediatric Patients with Beta-Thalassemia following Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 17(6). 861–866. 50 indexed citations
17.
Serafini, Gianluca, Marco Andreani, M. Testi, et al.. (2009). Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia. Haematologica. 94(10). 1415–1426. 45 indexed citations
18.
Aiuti, Alessandro, Immacolata Brigida, Francesca Ferrua, et al.. (2009). Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID. Immunologic Research. 44(1-3). 150–159. 20 indexed citations
19.
Marín, David, Sarah Marktel, Richard Szydlo, et al.. (2003). Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfa. The Lancet. 362(9384). 617–619. 27 indexed citations
20.
Camba, Lionello, Luca Aldrighetti, Massimo Bernardi, et al.. (2001). Locoregional intrasplenic chemotherapy for hypersplenism in myelofibrosis. British Journal of Haematology. 114(3). 638–640. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julián Sevilla Breakdown of academic impact, for papers by Paolo de Fabritiis Breakdown of academic impact, for papers by W. Lange Breakdown of academic impact, for papers by Josu de la Fuente Breakdown of academic impact, for papers by Carmem Bonfim Breakdown of academic impact, for papers by Pietro Merli Breakdown of academic impact, for papers by B.R. Reeves Breakdown of academic impact, for papers by Rinat Bernstein‐Molho Breakdown of academic impact, for papers by N. M. Wulffraat Breakdown of academic impact, for papers by Petr Sedláček
Rankless by CCL
2026